Search all medical codes
Malignant neoplasm of anterior wall of bladder
ICD10CM code
#### Name of the Condition
- Malignant neoplasm of the anterior wall of the bladder
- Bladder cancer affecting the anterior wall
#### Summary
Malignant neoplasm of the anterior wall of the bladder refers to cancer that originates on the front wall of the bladder. This type of cancer involves abnormal cell growth within the bladder that can invade and damage surrounding tissues and organs.
#### Causes
The exact cause of bladder cancer is not fully understood, but several factors are known to contribute to the risk of developing the condition, such as genetic mutations in bladder cells.
#### Risk Factors
- Smoking: Tobacco use significantly increases the risk for bladder cancer.
- Occupational exposure to specific chemicals: Such as those used in the dye, rubber, leather, textiles, and paint industries.
- Age: Most bladder cancers occur in people over 55.
- Gender: Males are more likely to develop bladder cancer than females.
- Chronic bladder inflammation or infections.
#### Symptoms
- Blood in the urine (hematuria)
- Frequent urination or urgent need to urinate
- Painful urination
- Pelvic pain
#### Diagnosis
- Urinalysis: To detect blood or cancer cells in urine.
- Cystoscopy: A procedure where a thin, lighted tube is inserted through the urethra to examine the bladder.
- Biopsy: A sample of bladder tissue is removed during cystoscopy to look for cancer cells.
- Imaging tests: CT scans, MRI, or ultrasound to visualize the bladder and surrounding areas.
#### Treatment Options
- Surgery: To remove cancerous tissues, which can range from tumor resection to removal of the bladder (cystectomy).
- Chemotherapy: Drugs used to kill cancer cells, which may be administered before surgery (neoadjuvant) or after (adjuvant).
- Radiation therapy: High-energy rays directed at the bladder to destroy cancer cells, often used in conjunction with chemotherapy.
- Immunotherapy: Boosts the immune system to fight cancer, often involving Bacillus Calmette-Guerin (BCG) therapy directly injected into the bladder.
#### Prognosis and Follow-Up
The prognosis largely depends on the cancer stage at diagnosis and response to treatment. Regular follow-up appointments are crucial for monitoring recurrence and managing any side effects of treatment. Early-stage cancers have a higher cure rate, while advanced cancers require more aggressive treatment and monitoring.
#### Complications
- Metastasis: If untreated, the cancer can spread to other parts of the body.
- Urinary incontinence: As a result of surgery or other treatments.
- Sexual dysfunction, depending on the impact of treatments on reproductive organs and nerves.
#### Lifestyle & Prevention
- Quit smoking: Tobacco cessation drastically reduces the risk of bladder cancer.
- Limit exposure to harmful chemicals by using proper protection in workplaces.
- Maintain adequate hydration: Drinking plenty of fluids may dilute harmful substances in the bladder.
- Regular screenings for high-risk individuals.
#### When to Seek Professional Help
Seek medical attention if experiencing unexplained blood in the urine, frequent or painful urination, or persistent pelvic pain.
#### Additional Resources
- American Cancer Society: [www.cancer.org](https://www.cancer.org/)
- Bladder Cancer Advocacy Network: [www.bcan.org](https://www.bcan.org/)
- National Cancer Institute: [www.cancer.gov](https://www.cancer.gov/)
#### Tips for Medical Coders
- Ensure the specific location of the neoplasm is accurately documented as the anterior wall of the bladder.
- Verify whether the condition is primary or metastatic when coding.
- Common errors include coding for bladder cancer without specifying the site or mistaking non-cancerous conditions for malignant neoplasms.